Adding Molecular Data to Prognostic Models can Improve their Predictive Power in Treated Patients with Myelodysplastic Syndromes (MDS). (April 2017) - Nazha, A.; Al-Issa, K.; Zarzour, A.; Radivoyevitch, T.; Hamilton, B.; Gerds, A.; Mukherjee, S.; Adema, V.; Clemente, M.; Patel, B.; Hirsch, C.; Advani, A.; et al.